Patent · US Active

Compositions including triciribine and taxanes and methods of use thereof

US9498492B2 · kind B2 · utility

1Cited by

21References

14Claims

0Family size

Assignee

University of South Florida · US

Inventors

Jin Q. Cheng · Tampa, US
Said M. Sebti · Tampa, US

Key dates

Filing date	Jul 1, 2015
Grant date	Nov 22, 2016
Priority date	—
Expiry date	Jul 1, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/912
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to combination therapies including triciribine and related compounds and taxanes and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.